Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-24

Clinical Trial Update: Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal Women [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update studying the absorption, metabolism, excretion, and absolute oral bioavailability of amcenestrant (SAR439859) in healthy post-me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amcenestrant (SAR439859)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer, Healthy Volunteers | Phase 1 | Status: COMPLETED